Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).
alcohol
cohort studies
cutaneous melanoma
epidemiology
keratinocyte cancers
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
revised:
16
06
2022
received:
12
03
2022
accepted:
05
07
2022
pubmed:
3
9
2022
medline:
17
12
2022
entrez:
2
9
2022
Statut:
ppublish
Résumé
Experimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country-specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal-cell carcinoma (BCC): n = 8711; squamous-cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow-up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1-4.9 g/day: HR = 1.44, 95% CI = 1.17-1.77; P
Identifiants
pubmed: 36053839
doi: 10.1002/ijc.34253
pmc: PMC10087036
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
348-362Subventions
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Informations de copyright
© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Br J Dermatol. 2014 Dec;171(6):1451-7
pubmed: 25059635
J Natl Cancer Inst. 2009 Mar 4;101(5):296-305
pubmed: 19244173
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1042-51
pubmed: 15184262
Public Health Nutr. 2005 Dec;8(8):1307-14
pubmed: 16372927
Br J Dermatol. 2014 May;170(5):1021-8
pubmed: 24495200
Am J Clin Nutr. 2015 Nov;102(5):1158-66
pubmed: 26423390
Am J Health Behav. 2018 Jan 1;42(1):85-98
pubmed: 29320342
Ann Epidemiol. 1993 May;3(3):235-8
pubmed: 8275194
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
Am J Epidemiol. 2006 Aug 1;164(3):232-45
pubmed: 16524953
Int J Cancer. 2023 Feb 1;152(3):348-362
pubmed: 36053839
Acta Oncol. 2000;39(5):611-6
pubmed: 11093369
Food Chem Toxicol. 2008 Aug;46(8):2903-11
pubmed: 18577414
Arch Dermatol. 2003 Aug;139(8):1003-6
pubmed: 12925386
Eur J Clin Nutr. 2008 Feb;62(2):162-70
pubmed: 17392700
Nutr Cancer. 2016 May-Jun;68(4):545-553
pubmed: 27145335
Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1540-3
pubmed: 14693751
JAMA Dermatol. 2019 Jan 1;155(1):39-49
pubmed: 30477003
Nat Rev Cancer. 2007 Aug;7(8):599-612
pubmed: 17646865
Br J Dermatol. 2003 Jul;149(1):115-23
pubmed: 12890204
Eur J Nutr. 2018 Oct;57(7):2323-2332
pubmed: 29327230
J Am Acad Dermatol. 2006 Oct;55(4):584-9
pubmed: 17010736
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1550-1558
pubmed: 27909090
Cancer Causes Control. 2014 Jan;25(1):1-10
pubmed: 24173533
Clin Exp Dermatol. 2010 Jan;35(1):7-11
pubmed: 19778305
Br J Cancer. 2014 Jul 8;111(1):203-6
pubmed: 24874476
J Invest Dermatol. 2012 Dec;132(12):2718-26
pubmed: 22696059
Int J Cancer. 1997 Jun 11;71(6):917-23
pubmed: 9185689
Addiction. 2009 Apr;104(4):533-50
pubmed: 19335652
Arch Dermatol. 2001 Sep;137(9):1162-8
pubmed: 11559211
Eur J Cancer Prev. 2004 Dec;13(6):503-8
pubmed: 15548944
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Alcohol. 2008 Mar;42(2):137-42
pubmed: 18358993
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur J Cancer. 2005 Sep;41(14):2040-59
pubmed: 16125929
Br J Dermatol. 2005 Mar;152(3):481-8
pubmed: 15787817
Int J Cancer. 2003 Oct 20;107(1):119-26
pubmed: 12925966
Skin Pharmacol Physiol. 2013;26(1):45-51
pubmed: 23147451
Lancet Oncol. 2021 Aug;22(8):1071-1080
pubmed: 34270924
Br J Dermatol. 2012 May;166(5):1069-80
pubmed: 22251204
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2222-31
pubmed: 24083994
Arch Dermatol Res. 2015 Nov;307(9):819-28
pubmed: 26179744
Br J Dermatol. 2017 Sep;177(3):696-707
pubmed: 28745396